Shire might dial up its $30B Baxalta offer, but not without more info

Baxalta ($BXLT) CEO Ludwig Hantson's dismissals of Shire's ($SHPG) $30 billion advance have always left room for the possibility that a bigger offer could get a conversation started. And Shire may consider upping its pitch, but first it needs more details on the financial future of its target, according to reports. More from FiercePharma